🇺🇸 FDA
Patent

US 7622107

Recombinant intracellular pathogen immunogenic compositions and methods for use

granted A61KA61K2039/522A61K2039/523

Quick answer

US patent 7622107 (Recombinant intracellular pathogen immunogenic compositions and methods for use) held by The Regents of the University of California expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K2039/522, A61K2039/523, A61K2039/545, A61K39/04